内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

10x Genomics, Inc.

TXG · Nasdaq · CIK 0001770787 · Healthcare · Medical Devices

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

46 同一窗口内观察到的 Form 4 交易行
38 sales · 8 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-02-21 · MATEO ALAN · $445.6K

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Saxonov SergeChief Executive Officer
▼▼▼○▼▼○▼
SULIMAN SHEHNAAZDirector
○▼▼▼
Teichmann Sarah A.Director
○▼▼
STUELPNAGEL JOHN RDirector
○▼▼
Taich AdamChief Financial Officer
▼▼▼
Hindson Benjamin J.See Remarks
▼▼
● 买入▼ 卖出○ 其他

Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-02-21 · MATEO ALAN.

近期 Form 4 活动

0买入
50卖出
13其他 Form 4 交易行
38SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出38 sale line(s) · 仅供背景
其他8 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
15,371,598
上期报告
16,692,300
日均成交量
3,393,658
回补天数
4.5

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-02-21MATEO ALAN买入 (P)Class A Common Stock40,000USD 11.14USD 445,600SEC 申报 ↗
2022-05-13McAnear Justin J.买入 (P)Class A Common Stock158USD 40.49USD 6,397SEC 申报 ↗
2022-05-13CRUTCHFIELD BRADFORD买入 (P)Class A Common Stock158USD 40.49USD 6,397SEC 申报 ↗

Form 4 申报证据

63 transaction lines in the latest 365-day window; 1,221 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-22Saxonov Serge卖出 (S)Class A Common Stock25,000USD 81.22USD 2,030,593SEC 申报 ↗
2026-09-22SULIMAN SHEHNAAZ卖出 (S)Class A Common Stock5,723USD 81.19USD 464,677SEC 申报 ↗
2026-09-09Taich Adam卖出 (S)Class A Common Stock46,388USD 64.58USD 2,995,519SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-22Saxonov Serge卖出 (S)Class A Common Stock25,000USD 81.22USD 2,030,593SEC 申报 ↗
2026-09-22SULIMAN SHEHNAAZ卖出 (S)Class A Common Stock5,723USD 81.19USD 464,677SEC 申报 ↗
2026-09-09Taich Adam卖出 (S)Class A Common Stock46,388USD 64.58USD 2,995,519SEC 申报 ↗
2026-09-03STUELPNAGEL JOHN R卖出 (S)Class A Common Stock20,000USD 61.76USD 1,235,120SEC 申报 ↗
2026-09-01Saxonov Serge赠与 (G)Class A Common Stock100USD 0.00USD 0SEC 申报 ↗
2026-08-26Saxonov Serge卖出 (S)Class A Common Stock10,486USD 63.70USD 667,913SEC 申报 ↗
2026-08-24Taich Adam卖出 (S)Class A Common Stock17,166USD 63.02USD 1,081,801SEC 申报 ↗
2026-08-24Saxonov Serge卖出 (S)Class A Common Stock18,545USD 63.02USD 1,168,706SEC 申报 ↗
2026-08-24SULIMAN SHEHNAAZ卖出 (S)Class A Common Stock2,207USD 63.65USD 140,486SEC 申报 ↗
2026-08-24Hindson Benjamin J.卖出 (S)Class A Common Stock13,818USD 63.02USD 870,810SEC 申报 ↗
2026-08-20Saxonov Serge赠与 (G)Class A Common Stock4,000USD 0.00USD 0SEC 申报 ↗
2026-08-14Teichmann Sarah A.卖出 (S)Class A Common Stock2,273USD 57.15USD 129,902SEC 申报 ↗
2026-08-13Teichmann Sarah A.卖出 (S)Class A Common Stock5,278USD 57.29USD 302,377SEC 申报 ↗
2026-08-11STUELPNAGEL JOHN R卖出 (S)Class A Common Stock20,000USD 57.75USD 1,155,050SEC 申报 ↗
2026-06-22Saxonov Serge卖出 (S)Class A Common Stock30,000USD 34.44USD 1,033,295SEC 申报 ↗
2026-06-16SULIMAN SHEHNAAZ卖出 (S)Class A Common Stock5,723USD 32.63USD 186,760SEC 申报 ↗
2026-06-04Teichmann Sarah A.奖励／授予 (A)Class A Common Stock8,829USD 0.00USD 0SEC 申报 ↗
2026-06-04SULIMAN SHEHNAAZ奖励／授予 (A)Class A Common Stock8,829USD 0.00USD 0SEC 申报 ↗
2026-06-04STUELPNAGEL JOHN R奖励／授予 (A)Class A Common Stock8,829USD 0.00USD 0SEC 申报 ↗
2026-06-04Popovits Kimberly J奖励／授予 (A)Class A Common Stock8,829USD 0.00USD 0SEC 申报 ↗
2026-06-04MATEO ALAN奖励／授予 (A)Class A Common Stock8,829USD 0.00USD 0SEC 申报 ↗
2026-06-04Kosaraju Sridhar奖励／授予 (A)Class A Common Stock8,829USD 0.00USD 0SEC 申报 ↗
2026-05-26Saxonov Serge卖出 (S)Class A Common Stock10,718USD 24.71USD 264,842SEC 申报 ↗
2026-05-22Taich Adam卖出 (S)Class A Common Stock15,098USD 24.44USD 368,995SEC 申报 ↗
2026-05-22Saxonov Serge卖出 (S)Class A Common Stock18,175USD 24.44USD 444,197SEC 申报 ↗
2026-05-22Hindson Benjamin J.卖出 (S)Class A Common Stock11,595USD 24.44USD 283,382SEC 申报 ↗
2026-04-14Saxonov Serge卖出 (S)Class A Common Stock5,000USD 24.56USD 122,800SEC 申报 ↗
2026-03-24Saxonov Serge卖出 (S)Class A Common Stock5,000USD 19.52USD 97,600SEC 申报 ↗
2026-03-23Saxonov Serge卖出 (S)Class A Common Stock10,000USD 19.13USD 191,300SEC 申报 ↗
2026-03-03Saxonov Serge赠与 (G)Class A Common Stock2,750USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码TXG
CIK0001770787
行业Healthcare
细分行业Medical Devices Yahoo Finance
SEC SIC3826 Laboratory Analytical Instruments
交易所Nasdaq

数据覆盖

本地 Form 4 历史1,221 transaction lines from 2020-01-03 to 2026-09-22
3 P purchase lines · 936 S sale lines · 282 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.